CompletedNCT04463108
Routine Treatment Pathways for Depression With Suicidal Thoughts
About this title
A Study to Describe Routine Treatment Pathways in Participants With Major Depression and Active Suicidal Ideation With Intent in Italy
Read the official source — NCT04463108Observational studyAges 18–74Italy
Understand this study
Who was this study for?
Listed age limits: 18 years to 74 years.
- Listed locations
- Brescia and 23 more locationsSee all locations and recruitment
Study information
Study start dateStarted: June 23, 2020
- Recruitment status
- Completed
- Enrollment listed in the registry
- 136
- Sponsor
- Janssen-Cilag S.p.A.
- Sponsor type
- Unknown or unclear
- Study type
- Observational
- Intervention type
- OTHER
- Study phase
- Not clearly listed
- Locations
- Italy
- Age range
- From 18 Years to 74 Years
- Official registry ID
- NCT04463108
- Official title
Show the full official title
A Description of Routine Treatment Pathways in a Cohort of Patients With Major Depression and "Active Suicidal Ideation With Intent" in Italy: the Arianna Observational Study.
Get this study by email
Recruitment & locations
CompletedBrescia · Cagliari · Cantù
20 more locations
- Catania
- Colleferro
- Foggia
- Frattamaggiore
- Genova
- Lido di Camaiore
- Milan
- Modena
- Oliveto Citra
- Orbassano
- Padova
- Palermo
- Province of Macerata
- Putignano
- Rimini
- Roma
- Teramo
- Torino
- Udine
- Vicenza
Questions about this study
Who is behind this study?
The study sponsor is Janssen-Cilag S.p.A.
Who was this study for?
Listed age limits: 18 years to 74 years.
Want to explore more studies?
Explore studiesRelated studies
Randomized evaluation of the effectiveness of lithium in subjects with treatment-resistant depression and Suicide prevention. An independent, pragmatic, multicentre, parallel-group, superiority trial.
Intranasal Esketamine for Imminent Suicide Risk in Adolescents
